HIVE’s fiscal second-quarter results are due after the market closes on November 9. Analysts expect a loss of C$0.15 per share and revenue of about US$88.25 million. HIVE missed EPS estimates in each of its last four comparable quarters, so investors will be watching its losses and revenue closely.
HIVE DIGITAL TECHNOLOGIES LTD (TSX: HIVE) will report results for the quarter ended September 30, 2026, after the market closes on November 9. The company has scheduled an earnings call for November 10, according to its announcement. One analyst expects a loss of C$0.15 per share, while eight analysts forecast revenue of US$88.25 million. That revenue estimate represents 1.1% year-over-year growth. The EPS estimate compares with a loss of C$0.10 a year earlier.
Recent earnings trend
HIVE DIGITAL TECHNOLOGIES LTD
HIVE.TO
HIVE.TO
HIVE DIGITAL TECHNOLOGIES LTD
WealthAwesomeMarket cap
$696.66M
52W high
$7.56
52W low
$2.23
1W change
-14.77%
Beta
3.54
Analyst Price Targets
Based on analyst covering HIVE · as of Sep 29, 2026
Wall Street analysts forecast HIVE stock price to rise 420.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$8.48
+420.4% Upside
Current Price
C$1.63
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HIVE's historical volatility
30-Day Vol
67.8%
Annualized
90-Day Vol
87.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.92
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.17 | C$1.71 – C$2.74 |
| 60 trading days | C$2.04 | C$1.47 – C$2.84 |
| 90 trading days | C$1.92 | C$1.28 – C$2.89 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-09 | — | -0.1000 | — |
| 2026-06-30 | 2026-08-14 | -0.2600 | -0.1500 | -73.3% |
| 2026-03-31 | 2026-03-31 | -0.4149 | -0.2986 | -38.9% |
| 2025-12-31 | 2026-02-16 | -0.5200 | -0.1000 | -420.0% |
| 2025-09-30 | 2025-11-14 | -0.1000 | 0.0300 | -433.3% |
| 2025-06-30 | 2025-08-14 | 0.2500 | -0.1000 | +350.0% |
HIVE has missed EPS estimates in each of its last four reported quarters. This report will show whether that pattern continues and whether revenue growth is helping improve profitability. See the HIVE stock page for company and share information.
Investor takeaway: The outlook is challenging. Analysts expect a larger per-share loss than a year ago, and HIVE has missed EPS estimates in its last four comparable quarters. Revenue is forecast to grow modestly, but that estimate alone doesn’t show whether growth will improve margins or reduce losses. Only one analyst contributed to the EPS consensus, so treat it as a limited benchmark rather than a broad market view.
C$0.15 loss per share
That’s the consensus EPS estimate for the September quarter, based on one analyst. The estimate was revised down from C$0.00 30 days ago. HIVE missed EPS estimates in each of its last four reported quarters. Eight analysts expect revenue of US$88.25 million.
Bull case
Analysts expect modest year-over-year revenue growth, and HIVE has been building its business around high-performance computing and AI infrastructure. Recent company announcements include an AI cloud services agreement and financing to support the expansion of sovereign AI infrastructure. If HIVE reports stronger revenue and shows how these investments can support future operations, investors may see a more promising growth outlook. The results and operating details will need to back up that case.
Bear case
HIVE missed EPS estimates in each of its last four reported quarters. Actual EPS was -C$0.26 versus an estimate of -C$0.15 for the quarter ended June 30; -C$0.4149 versus -C$0.2986 for March 31; -C$0.52 versus -C$0.10 for December 31; and -C$0.10 versus an estimate of C$0.03 for September 30, 2025. Analysts expect another loss this quarter, and HIVE’s supplied fundamentals show negative trailing EPS and a negative profit margin. Even if revenue grows, investors may want to see progress on losses and profitability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
